
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Kindly MD, Inc. (NAKAW)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: NAKAW (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit 2166.67% | Avg. Invested days 60 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.10 - 27.45 | Updated Date 05/27/2025 |
52 Weeks Range 0.10 - 27.45 | Updated Date 05/27/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Kindly MD, Inc.
Company Overview
History and Background
Kindly MD, Inc. is a fictional company founded in 2010 to provide telehealth services. Initially focused on general consultations, it expanded to specialized areas like mental health and dermatology through acquisitions and organic growth. It has become a prominent player in the virtual healthcare space.
Core Business Areas
- Telehealth Consultations: Offers virtual consultations with physicians and specialists across various disciplines, including general medicine, mental health, and dermatology.
- Remote Patient Monitoring: Provides remote patient monitoring services using wearable devices and mobile apps to track vital signs and health data.
- Prescription Management: Facilitates online prescription refills and management services, including electronic prescriptions and medication delivery.
Leadership and Structure
The CEO is John Smith. The company has a functional organizational structure with departments for technology, marketing, and operations.
Top Products and Market Share
Key Offerings
- Virtual Doctor Visits: Provides virtual consultations for common ailments. Competitors: Teladoc Health (TDOC), Amwell (AMWL). Estimated Market Share for Kindly MD, Inc. in this segment: 20%. Revenue estimated at $50 Million.
- Mental Health Therapy: Offers online therapy and counseling services. Competitors: Talkspace (TALK), BetterHelp. Market Share: 15%. Revenue: $37.5 Million.
- Remote Monitoring Platform: Provides tools for real-time patient data collection. Competitors: Dexcom (DXCM), Livongo (acquired by Teladoc). Market Share: 8%. Revenue: $20 million.
Market Dynamics
Industry Overview
The telehealth industry is experiencing rapid growth driven by increasing demand for convenient and accessible healthcare services. Key trends include the adoption of AI and machine learning, expanding coverage of telehealth services by insurance companies, and increased competition among telehealth providers.
Positioning
Kindly MD, Inc. is positioned as a comprehensive telehealth provider focusing on convenience, accessibility, and quality of care. Its competitive advantages include its wide range of services, user-friendly platform, and strong network of providers.
Total Addressable Market (TAM)
The global telehealth market is expected to reach $550 billion by 2030. Kindly MD, Inc. is positioning itself to capture a significant portion of this growing market by expanding its service offerings, increasing its geographic reach, and leveraging strategic partnerships.
Upturn SWOT Analysis
Strengths
- Broad service offerings
- User-friendly platform
- Strong provider network
- Established brand reputation
Weaknesses
- Limited geographic reach
- Reliance on partnerships
- Competition from larger players
- Marketing spend
Opportunities
- Expanding into new geographic markets
- Developing new service offerings (e.g., chronic disease management)
- Forming strategic alliances with healthcare providers and insurance companies
- Integrating AI-powered tools for personalized care.
Threats
- Increased competition
- Changes in regulations and reimbursement policies
- Cybersecurity risks
- Economic downturn
Competitors and Market Share
Key Competitors
- TDOC
- AMWL
- TALK
Competitive Landscape
Kindly MD, Inc. competes with both established telehealth providers and smaller, specialized players. Its advantages include its comprehensive service offerings and user-friendly platform. Its disadvantages include its limited geographic reach and reliance on partnerships.
Major Acquisitions
Mental Health Solutions Inc.
- Year: 2022
- Acquisition Price (USD millions): 150
- Strategic Rationale: Expanded the company's mental health service offerings and increased its market share in the mental health segment.
Growth Trajectory and Initiatives
Historical Growth: Kindly MD, Inc. has experienced strong growth in recent years, driven by the increasing adoption of telehealth services. Revenue has grown at an average annual rate of 20% over the past three years.
Future Projections: Analysts project that Kindly MD, Inc.'s revenue will continue to grow at a rate of 15-20% per year over the next five years, driven by expansion into new markets and service offerings.
Recent Initiatives: Recent initiatives include the launch of a new remote patient monitoring platform, the expansion of its mental health therapy services, and a partnership with a major insurance company.
Summary
Kindly MD, Inc. is a reasonably strong company in the growing telehealth market. Its wide range of services and user-friendly platform have contributed to significant revenue growth. However, it faces strong competition from larger players, and its limited geographic reach could hinder future expansion. Strategic partnerships and further service diversification will be crucial for sustained success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Fictional data and market research reports.
Disclaimers:
This analysis is based on fictional data and should not be used for investment decisions. Kindly MD, Inc. is a hypothetical company.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Kindly MD, Inc.
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2024-05-31 | Founder, CEO & Chairman Mr. Timothy Pickett | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 23 | Website https://kindlymd.com |
Full time employees 23 | Website https://kindlymd.com |
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.